Mangalam Drugs & Organics Limited (NSE:MANGALAM)

India flag India · Delayed Price · Currency is INR
69.50
-0.69 (-0.98%)
Oct 20, 2025, 3:29 PM IST
-0.98%
Market Cap1.11B
Revenue (ttm)2.98B
Net Income (ttm)-97.62M
Shares Outn/a
EPS (ttm)-6.17
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,653
Average Volume23,252
Open70.19
Previous Close70.19
Day's Range68.61 - 70.47
52-Week Range68.00 - 128.01
Beta-0.19
RSI39.39
Earnings DateNov 14, 2025

About Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaqui... [Read more]

Sector Healthcare
Founded 1972
Employees 480
Stock Exchange National Stock Exchange of India
Ticker Symbol MANGALAM
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.